Blue Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Blue Trust's XBI Position: Q3 2026 in Review
Blue Trust increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.71% in Q3 2026, buying an estimated $2.37K and bringing the position to 2,113 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #610.
Blue Trust first reported a position in XBI in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.44M in Q2 2022. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Blue Trust held 2,113 shares of State Street SPDR S&P Biotech ETF worth $333K as of Q3 2026.
- Blue Trust bought 15 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $2.37K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #610 holding.
- Blue Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 7 quarters since.
- Blue Trust's State Street SPDR S&P Biotech ETF position peaked at $1.44M in Q2 2022.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.